Inventor

Fa-Xiang Ding

Inventor
Staten Island, NY, US

Overview

22→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes27%
C07CAcyclic or carbocyclic compounds3%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,947,222Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2202110,407,421Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections201910,208,064Inhibitors of the renal outer medullary potassium channel201910,000,484Inhibitors of the renal outer medullary potassim channel20189,926,317'Inhibitors of the renal outer medullary potassium channel'20189,862,720'Inhibitors of the renal outer medullary potassium channel'20189,850,245Inhibitors of the renal outer medullary potassium channel20179,839,642'Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors'20179,839,629'Inhibitors of the renal outer medullary potassium channel'20179,765,074'Inhibitors of the renal outer medullary potassium channel'20179,718,808'Inhibitors of the renal outer medullary potassium channel'20179,708,336'Metallo-beta-lactamase inhibitors'20179,604,998'Inhibitors of the renal outer medullary potassium channel'20179,284,301'Soluble guanylate cyclase activators'20169,206,198'Inhibitors of the renal outer medullary potassium channel'20159,062,070'Inhibitors of the renal outer medullary potassium channel'20158,952,166'Inhibitors of the renal outer medullary potassium channel'20158,785,634'Spiropiperidine prolylcarboxypeptidase inhibitors'20148,455,520'Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment'20138,168,649'Niacin receptor agonists, compositions containing such compounds and methods of treatment'20127,923,466'3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I'20117,629,376'3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2021Based in Staten Island, NY, US· patent location history
2012–2017Patents assigned to DING FA-XIANG (6)· patent assignee history
2012–2016Patents assigned to SHEN HONG (4)· patent assignee history
2013–2021Patents assigned to MERCK SHARP & DOHME (19)· patent assignee history
2014–2021Patents assigned to JIANG JINLONG (6)· patent assignee history
2015–2019Patents assigned to DONG SHUZHI (4)· patent assignee history
2018Based in Kenilworth, NJ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME192013–2021
DING FA-XIANGself62012–2017
JIANG JINLONG62014–2021
DONG SHUZHI42015–2019
SHEN HONG42012–2016
Locations
LocationPatentsSpan
Staten Island, New York, US212009–2021
Kenilworth, New Jersey, US12018